BR9915513A - Interagentes de canal de potássio e usos para tais - Google Patents

Interagentes de canal de potássio e usos para tais

Info

Publication number
BR9915513A
BR9915513A BR9915513-3A BR9915513A BR9915513A BR 9915513 A BR9915513 A BR 9915513A BR 9915513 A BR9915513 A BR 9915513A BR 9915513 A BR9915513 A BR 9915513A
Authority
BR
Brazil
Prior art keywords
pcip
nucleic acid
acid molecules
proteins
expression vectors
Prior art date
Application number
BR9915513-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Kenneth Rhodes
Maria Betty
Huai-Pin Ling
Wenqian An
Original Assignee
Millennium Pharm Inc
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/298,731 external-priority patent/US6369197B1/en
Priority claimed from US09/350,874 external-priority patent/US20020019020A1/en
Priority claimed from US09/399,913 external-priority patent/US6361971B1/en
Priority claimed from US09/400,492 external-priority patent/US7115381B1/en
Application filed by Millennium Pharm Inc, American Home Prod filed Critical Millennium Pharm Inc
Publication of BR9915513A publication Critical patent/BR9915513A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9915513-3A 1998-11-20 1999-11-19 Interagentes de canal de potássio e usos para tais BR9915513A (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10933398P 1998-11-20 1998-11-20
US11003398P 1998-11-25 1998-11-25
US11027798P 1998-11-30 1998-11-30
US09/298,731 US6369197B1 (en) 1998-11-20 1999-04-23 Potassium channel interactors and uses therefor
US09/350,874 US20020019020A1 (en) 1998-11-20 1999-07-09 Methods for treating cardiovascular disorders
US09/350,614 US6689581B1 (en) 1998-11-20 1999-07-09 Potassium channel interactors and uses therefor
US09/399,913 US6361971B1 (en) 1998-11-20 1999-09-21 Nucleic acid molecules encoding potassium channel interactors and uses therefor
US09/400,492 US7115381B1 (en) 1998-11-20 1999-09-21 Methods for treating cardiovascular disorders
PCT/US1999/027428 WO2000031133A2 (en) 1998-11-20 1999-11-19 Potassium channel interactors and uses therefor

Publications (1)

Publication Number Publication Date
BR9915513A true BR9915513A (pt) 2002-02-05

Family

ID=27574798

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915513-3A BR9915513A (pt) 1998-11-20 1999-11-19 Interagentes de canal de potássio e usos para tais

Country Status (12)

Country Link
EP (1) EP1131349A2 (es)
JP (1) JP2002530104A (es)
CN (1) CN1346368A (es)
AU (1) AU775713B2 (es)
BR (1) BR9915513A (es)
CA (1) CA2351365A1 (es)
CZ (1) CZ20011764A3 (es)
IL (1) IL143148A0 (es)
MX (1) MXPA01004903A (es)
NO (1) NO20012471L (es)
NZ (1) NZ512332A (es)
WO (1) WO2000031133A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
EA200300420A1 (ru) * 2000-09-27 2004-04-29 Милленниум Фамэсьютикэлс, Инк. Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты)
JP2012507273A (ja) * 2008-11-06 2012-03-29 ビーエーエスエフ ソシエタス・ヨーロピア 殺虫剤のスクリーニングアッセイ
GB201906482D0 (en) * 2019-05-08 2019-06-19 Evox Therapeutics Ltd Exosome comprising stabilized RNA therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4758997A (en) * 1996-10-17 1998-05-11 Nps Pharmaceuticals, Inc. Potassium channel blocking compounds and their use
US6117989A (en) * 1998-03-26 2000-09-12 Incyte Pharmaceuticals, Inc. Human calcium-binding proteins

Also Published As

Publication number Publication date
CN1346368A (zh) 2002-04-24
AU1479700A (en) 2000-06-13
CA2351365A1 (en) 2000-06-02
NO20012471D0 (no) 2001-05-18
WO2000031133A3 (en) 2000-10-05
MXPA01004903A (es) 2003-03-10
JP2002530104A (ja) 2002-09-17
WO2000031133A2 (en) 2000-06-02
NZ512332A (en) 2004-02-27
NO20012471L (no) 2001-07-18
CZ20011764A3 (cs) 2002-01-16
AU775713B2 (en) 2004-08-12
IL143148A0 (en) 2002-04-21
EP1131349A2 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
BR0013542A (pt) Moléculas b7-4 e usos para as mesmas
WO2001062794A3 (en) 18607, a human calcium channel
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
EP1009752A4 (en) NOVEL TANGO-77 PROTEIN FAMILY MOLECULES AND USES THEREOF
ATE352561T1 (de) Pgc-1, ein neuartiger ppar-gamma-koaktivator aus braunem fettgewebe
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
BR9915513A (pt) Interagentes de canal de potássio e usos para tais
BR0109524A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, método para produzir um polipeptìdeo, polipeptìdeo isolado, anticorpo, método para detectar a presença de um polipeptìdeo em uma amostra, kit, e, métodos para detectar a presença de uma molécula de ácido nucleico em uma amostra, para identificar um composto e para modular a atividade de um polipeptìdeo
MXPA04004561A (es) Distribuidor de aire para sistema de biolixiviacion.
WO2000039149A3 (en) Secreted proteins and uses thereof
DE60237613D1 (de) Neue pgc-1-isoformen und deren verwendungen
DK1183355T3 (da) T-BET-præparater og fremgangsmåder til fremstilling heraf
WO2000052164A3 (en) Potassium channel molecules and uses therefor
BR0114383A (pt) Interatuadores de canais de potássio e aplicações dos mesmos
ATE433489T1 (de) 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
ATE419350T1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc- 2
WO2001083752A3 (en) 23949 and 32391, human ion channels and uses thereof
WO2001068857A3 (en) 18615 and 48003, human ion channels and uses therefor
WO2001094412A3 (en) 56201, a novel human sodium ion channel family member and uses thereof
WO2001032872A3 (en) Twik potassium channel molecules and uses therefor
DE60124910D1 (de) Menschliche twik-8 moleküle und ihre verwendung
BR0116420A (pt) proteìnas moduladoras de receptores de glutamato e moléculas de ácidos nucléicos e aplicações das mesmas
ATE445714T1 (de) 15603, ein mitglied der humanen ionenkanal- familie
WO2002024898A3 (en) 47647, a human lipase and uses therefor
WO2002026948A3 (en) 55054, a human metalloprotease and uses therefor

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: MILLENNIUM PHARMACEUTICALS, INC. (US), WYETH (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.